Donna Hofmeister thought she and her husband would be having sex for the rest of their lives. “I was someone that would always say to my husband, ‘I want to be doing it when we’re 80,’” Hofmeister, 54 ...
Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...
I frequently hear complaints of decreased libido in perimenopausal and menopausal women on hormone replacement therapy, even after they have tried estrogen and progesterone replacement or testosterone ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results